Amicus Therapeutics, Inc. (FOLD)

Amicus Therapeutics Revenue

Amicus Therapeutics had revenue of $423.49M in the twelve months ending March 31, 2024, with 25.74% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $110.40M with 27.97% year-over-year growth. In the year 2023, Amicus Therapeutics had annual revenue of $399.36M with 21.30% growth.

• Revenue (ttm): $423.49M
• Revenue Growth: +25.74%
• P/S Ratio: 6.89
• Revenue / Employee: $819,128
• Employees: 517
• Market Cap: 2.92B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	399.36M	70.12M	21.30%
Dec 31, 2022	329.23M	23.72M	7.76%
Dec 31, 2021	305.51M	44.63M	17.11%
Dec 31, 2020	260.89M	78.65M	43.16%
Dec 31, 2019	182.24M	90.99M	99.72%
Dec 31, 2018	91.25M	54.32M	147.08%
Dec 31, 2017	36.93M	31.97M	644.86%
Dec 31, 2016	4.96M	-	-
Dec 31, 2015	0	-	-
Dec 31, 2014	1.22M	861.00K	237.19%
Dec 31, 2013	363.00K	-18.05M	-98.03%
Dec 31, 2012	18.41M	-3.02M	-14.10%
Dec 31, 2011	21.43M	20.51M	2,224.73%
Dec 31, 2010	922.00K	-63.44M	-98.57%
Dec 31, 2009	64.36M	49.39M	330.00%
Dec 31, 2008	14.97M	13.18M	738.96%
Dec 31, 2007	1.78M	-	-
Dec 31, 2006	0	-	-
Dec 31, 2005	0	-	-
Dec 31, 2004	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.